以“急则治标,缓则治本”探析哮喘缓解期 患者的临证举隅
A Case Analysis of Asthma in Remission Guided by the Principle of “Symptomatic Treatment in Acute Stage and Radical Treatment in Chronic Stage”
摘要: 支气管哮喘属中医“哮病”范畴,缓解期病机多为本虚标实,以肺脾肾阳虚为本,寒饮痰湿伏肺为标,病情易反复迁延。本文以1例哮喘缓解期痰湿内蕴患者为研究对象,探析“急则治标,缓则治本”治则指导下,以从肺、到脾、到肾为核心的递进式治疗思路。分期用药逐层祛伏痰、补脏腑,患者咳喘痰多、肢体困重等痰湿证候逐步消失,机体正气复健。证实标本分治、循序调补肺脾肾,是改善痰湿型哮喘缓解期的有效治法。标本有序、攻补兼施,临床疗效确切,可为哮喘缓解期痰湿证的中医辨证治疗提供参考。
Abstract: Bronchial asthma falls under the category of “wheezing disorder” (Xiao Bing) in traditional Chinese medicine (TCM). During the remission phase, the pathogenesis is predominantly characterized by root deficiency and branch excess, with Yang deficiency of the Lung, Spleen, and Kidney as the root cause, and cold fluid, phlegm, and dampness lurking in the Lung as the branch manifestation, leading to recurrent and protracted episodes. This paper takes a patient with phlegm-dampness internal accumulation during asthma remission as the research subject, and explores a progressive treatment strategy—from the Lung, to the Spleen, and then to the Kidney—guided by the principle of “treating the manifestation in acute cases and the root cause in chronic cases”. Through staged medication, the latent phlegm was gradually eliminated and the viscera were supplemented in layers. The patient’s dampness-phlegm symptoms, such as wheezing, copious sputum, and heavy limbs, progressively resolved, and the body’s healthy qi was restored. This confirms that differentiating treatment between manifestation and root causes, along with sequential tonification of the Lung, Spleen, and Kidney, is an effective therapeutic approach for improving phlegm-dampness type asthma in remission. With orderly differentiation between root and branch, and combined attack and supplementation, the clinical efficacy is definite, providing a reference for TCM syndrome differentiation and treatment of phlegm-dampness pattern in asthma remission.
文章引用:杨婉婷, 张碧海. 以“急则治标,缓则治本”探析哮喘缓解期 患者的临证举隅[J]. 临床医学进展, 2026, 16(7): 1560-1564. https://doi.org/10.12677/acm.2026.1672676

参考文献

[1] 中华医学会呼吸病学分会. 支气管哮喘防治指南(2024年版) [J]. 中华结核和呼吸杂志, 2025, 48(3): 208-248.
[2] Papi, A., Chipps, B.E., Beasley, R., Panettieri, R.A., Israel, E., Cooper, M., et al. (2022) Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma. New England Journal of Medicine, 386, 2071-2083. [Google Scholar] [CrossRef] [PubMed]
[3] 洪日. 徐艳玲教授从肺脾肾论治支气管哮喘缓解期经验[D]: [硕士学位论文]. 沈阳: 辽宁中医药大学, 2014.
[4] 李红念, 梅全喜, 戴卫波, 等. 玉屏风散的临床应用与药理作用研究进展[J]. 广州中医药大学学报, 2016, 33(2): 284-287.
[5] 马效东. 六君子汤加减治疗小儿支气管哮喘的疗效及对免疫功能的影响[J]. 全科医学临床与教育, 2018, 16(1): 82-84.
[6] 余荣祥, 宋德胤. 培土生金中药联合西医常规疗法治疗支气管哮喘缓解期肺脾两虚证的Meta分析及GRADE质量评价[J]. 江西中医药, 2026, 57(1): 45-49.
[7] 史同霞, 王学华. 金匮肾气丸的药理研究及临床应用进展[J]. 中央民族大学学报(自然科学版), 2019, 28(2): 68-71.
[8] 潘霞. 从肺脾肾论治哮病缓解期的临床探析及中医辨证论治文献研究[D]: [硕士学位论文]. 沈阳: 辽宁中医药大学, 2020.
[9] 赵欣, 王祺. 哮喘夙根与痰饮血瘀关系初探[J]. 中医临床研究, 2017, 9(11): 147-148.
[10] 陈旭, 王洋, 薛晓明, 等. 平喘方透皮贴治疗支气管哮喘缓解期(肺肾阳虚证)的临床观察[J]. 中国民间疗法, 2026, 34(1): 94-98.
[11] 王素花, 王明航, 王欣. 化痰益肺方联合穴位敷贴治疗支气管哮喘缓解期疗效观察[J]. 辽宁中医杂志, 2026, 53(5): 121-124.
[12] 刘森海. 肺为贮痰之器脾为生痰之源与中医水液代谢[J]. 天津医科大学学报, 1998, 4(2): 81-83.